Impel NeuroPharma Inc.

NASDAQ:IMPL   3:59:54 PM EDT
14.16
-1.09 (-7.15%)
Earnings Announcements

Impel Neuropharma Announces Q2 Non-GAAP Loss Per Share Of $0.79

Published: 08/16/2021 12:12 GMT
Impel NeuroPharma Inc. (IMPL) - Impel Neuropharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update.
Q2 Non-GAAP Loss per Share $0.79.
Q2 GAAP Loss per Share $1.10.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.75

Next Quarter Revenue Guidance is expected to be $2.65 Million
Next Quarter EPS Guidance is expected to be -$0.73

More details on our Analysts Page.